First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

J. J. Ko; T. K. Choueiri; B. I. Rini; J. L. Lee; N. Kroeger; S. Srinivas; L. C. Harshman; J. J. Knox; G. A. Bjarnason; M. J. MacKenzie; L. Wood; U. N. Vaishampayan; N. Agarwal; S. K. Pal; M. H. Tan; S. Y. Rha; T. Yuasa; F. Donskov; A. Bamias; D. Y. Heng

doi:10.1038/bjc.2014.25

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

J. J. Ko, T. K. Choueiri, B. I. Rini, J. L. Lee, N. Kroeger, S. Srinivas, L. C. Harshman, J. J. Knox, G. A. Bjarnason, M. J. MacKenzie, L. Wood, U. N. Vaishampayan, N. Agarwal, S. K. Pal, M. H. Tan, S. Y. Rha, T. Yuasa, F. Donskov, A. Bamias, D. Y. Heng

Research output: Contribution to journal › Article › peer-review

65 Citations (Scopus)

Original language	English
Pages (from-to)	1917-1922
Number of pages	6
Journal	British Journal of Cancer
Volume	110
Issue number	8
DOIs	https://doi.org/10.1038/bjc.2014.25
Publication status	Published - Apr 15 2014
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bjc.2014.25

Cite this

Ko, J. J., Choueiri, T. K., Rini, B. I., Lee, J. L., Kroeger, N., Srinivas, S., Harshman, L. C., Knox, J. J., Bjarnason, G. A., MacKenzie, M. J., Wood, L., Vaishampayan, U. N., Agarwal, N., Pal, S. K., Tan, M. H., Rha, S. Y., Yuasa, T., Donskov, F., Bamias, A., & Heng, D. Y. (2014). First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. British Journal of Cancer, 110(8), 1917-1922. https://doi.org/10.1038/bjc.2014.25

Ko, JJ, Choueiri, TK, Rini, BI, Lee, JL, Kroeger, N, Srinivas, S, Harshman, LC, Knox, JJ, Bjarnason, GA, MacKenzie, MJ, Wood, L, Vaishampayan, UN, Agarwal, N, Pal, SK, Tan, MH, Rha, SY, Yuasa, T, Donskov, F, Bamias, A & Heng, DY 2014, 'First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.', British Journal of Cancer, vol. 110, no. 8, pp. 1917-1922. https://doi.org/10.1038/bjc.2014.25

@article{5b10527397114de8aba22bd8a6700c2f,

title = "First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.",

author = "Ko, {J. J.} and Choueiri, {T. K.} and Rini, {B. I.} and Lee, {J. L.} and N. Kroeger and S. Srinivas and Harshman, {L. C.} and Knox, {J. J.} and Bjarnason, {G. A.} and MacKenzie, {M. J.} and L. Wood and Vaishampayan, {U. N.} and N. Agarwal and Pal, {S. K.} and Tan, {M. H.} and Rha, {S. Y.} and T. Yuasa and F. Donskov and A. Bamias and Heng, {D. Y.}",

year = "2014",

month = apr,

day = "15",

doi = "10.1038/bjc.2014.25",

language = "English",

volume = "110",

pages = "1917--1922",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - First-, second-, third-line therapy for mRCC

T2 - benchmarks for trial design from the IMDC.

AU - Ko, J. J.

AU - Choueiri, T. K.

AU - Rini, B. I.

AU - Lee, J. L.

AU - Kroeger, N.

AU - Srinivas, S.

AU - Harshman, L. C.

AU - Knox, J. J.

AU - Bjarnason, G. A.

AU - MacKenzie, M. J.

AU - Wood, L.

AU - Vaishampayan, U. N.

AU - Agarwal, N.

AU - Pal, S. K.

AU - Tan, M. H.

AU - Rha, S. Y.

AU - Yuasa, T.

AU - Donskov, F.

AU - Bamias, A.

AU - Heng, D. Y.

PY - 2014/4/15

Y1 - 2014/4/15

UR - http://www.scopus.com/inward/record.url?scp=84901844215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901844215&partnerID=8YFLogxK

U2 - 10.1038/bjc.2014.25

DO - 10.1038/bjc.2014.25

M3 - Article

C2 - 24691425

AN - SCOPUS:84901844215

SN - 0007-0920

VL - 110

SP - 1917

EP - 1922

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 8

ER -

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this